Gregory Karen J, Conn P Jeffrey
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (K.J.G.); and Vanderbilt Center for Neuroscience Drug Discovery & Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C).
Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria, Australia (K.J.G.); and Vanderbilt Center for Neuroscience Drug Discovery & Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee (P.J.C)
Mol Pharmacol. 2015 Jul;88(1):188-202. doi: 10.1124/mol.114.097220. Epub 2015 Mar 25.
The metabotropic glutamate (mGlu) receptors are a group of eight family C G protein-coupled receptors that are expressed throughout the central nervous system (CNS) and periphery. Within the CNS the different subtypes are found in neurons, both pre- and/or postsynaptically, where they mediate modulatory roles and in glial cells. The mGlu receptor family provides attractive targets for numerous psychiatric and neurologic disorders, with the majority of discovery programs focused on targeting allosteric sites, with allosteric ligands now available for all mGlu receptor subtypes. However, the development of allosteric ligands remains challenging. Biased modulation, probe dependence, and molecular switches all contribute to the complex molecular pharmacology exhibited by mGlu receptor allosteric ligands. In recent years we have made significant progress in our understanding of this molecular complexity coupled with an increased understanding of the structural basis of mGlu allosteric modulation.
代谢型谷氨酸(mGlu)受体是一组8个C家族G蛋白偶联受体,在中枢神经系统(CNS)和外周均有表达。在中枢神经系统中,不同亚型存在于神经元中,在突触前和/或突触后发挥作用,介导调节功能,同时也存在于神经胶质细胞中。mGlu受体家族为众多精神和神经疾病提供了有吸引力的靶点,大多数发现计划都集中在靶向变构位点,目前所有mGlu受体亚型都有了变构配体。然而,变构配体的开发仍然具有挑战性。偏向性调节、探针依赖性和分子开关都导致了mGlu受体变构配体表现出复杂的分子药理学特性。近年来,我们在理解这种分子复杂性方面取得了重大进展,同时对mGlu变构调节的结构基础也有了更多了解。